Exogenous Indian hedgehog antagonist damages intervertebral discs homeostasis in adult mice
Background: Vismodegib, as an exogenous Indian hedgehog (Ihh) antagonist, has been approved by the Food and Drug Administration (FDA) for the clinical treatment of patients with basal cell carcinoma, and previous observations implicate the potential therapeutic of vismodegib in osteoarthritis treatm...
| 出版年: | Journal of Orthopaedic Translation |
|---|---|
| 主要な著者: | , , , , , , , , , , , , , |
| フォーマット: | 論文 |
| 言語: | 英語 |
| 出版事項: |
Elsevier
2022-09-01
|
| 主題: | |
| オンライン・アクセス: | http://www.sciencedirect.com/science/article/pii/S2214031X22000948 |
